The present study compared the acute dose effects of the benzodiazepine triazolam and the anticholinergic scopolamine on metamemory (knowledge and awareness of one's own memory) in a two-phase paradigm designed to assess effects on both monitoring and control components of metamemory in both semantic (general knowledge) and episodic memory (cued recall) tasks. Placebo and two doses each of triazolam (0.125, 0.25 mg/70 kg, oral) and scopolamine (0.25, 0.50 mg/70 kg, subcutaneous) were administered to 80 healthy volunteers (16/group) in a double-blind, doubledummy, independent groups design. Both triazolam and scopolamine impaired episodic memory (quantity and accuracy) but not semantic memory. Results suggested that both drugs impaired monitoring as reflected in absolute accuracy measures (impaired calibration in the direction of overconfidence) and control sensitivity (the relationship between confidence and behavior). Overall, the results did not provide evidence for differences between triazolam and scopolamine in memory or metamemory. In addition to the clinical relevance of the observed effects, this study adds to the accumulating body of cognitive psychopharmacological research illustrating the usefulness of druginduced amnesia as a vehicle to explore memory and metamemory.Metamemory, which refers to an individual's knowledge and awareness of his/her own memory (Flavell, 1971;Metcalfe & Shimamura, 1994), plays an important role in memory performance in many everyday situations. Metamemory can be thought of as encompassing two components: Monitoring, which consists of processes involved in an individual's selfassessment of his/her memory, and control, which refers to ways in which an individual can regulate cognitive processing when given the opportunity to do so (Nelson & Narens, 1990. One can take as an example an eyewitness in a courtroom who swears to "tell the truth, the whole truth, and nothing but the truth." Given that memory is a reconstructive process, the witness presumably must first assess the features of his/her memory of the event being discussed (monitoring) and then determine which features of that memory to report in court (i.e., which features reach the subjective threshold of "truth") (control).It is well established that benzodiazepine (e.g., diazepam: Valium®, lorazepam: Ativan®; triazolam: Halcion®) and anticholinergic (e.g., scopolamine) drugs induce temporary amnesia when administered acutely to healthy volunteers (for reviews, see Curran, 1991Curran, , 2000Kopelman, 1986;Polster, 1993). The effects of memory-impairing drugs on metamemory have both clinical and theoretical significance. From a clinical perspective, if a drug produces memory impairment, it is essential to know the degree to which patients being prescribed that
Publisher's Disclaimer:The following manuscript is the final accepted manuscript. It has not been subjected to the final copyediting, fact-checking, and proofreading required for formal publication. It is not the definitive, publisher-authenticated vers...